GM gene-edited tomatoes to be fed to humans (but no, it's not a food safety study)
By Claire Robinson,
GMWatch
| 09. 29. 2025
Researchers are recruiting vitamin D-deficient subjects to trial the GM tomato.
According to an article on BBC News, the Quadram Institute in Norwich is recruiting 76 people with low vitamin D to take part in the ViTaL-D Study, where some participants will eat soup containing tomatoes that have been genetically engineered via gene editing to contain a vitamin D precursor. When the fruit is placed under ultraviolet light, vitamin D forms.
Pat Thomas from Beyond GM was quoted by BBC News as saying there should be "an abundance of precaution" when it comes to GM foods that people have not eaten before.
While the BBC headlines its article on the GM vitamin D tomato study "Trial uses tomatoes to test impact of gene-edited food on humans" and touts it as probably "the first human trial in the UK", we should be under no illusions. This 21-day study is not a food safety study and it won't "test the impact of a gene-edited food on humans", in the sense of monitoring the health of GM tomato-consuming people over the medium or longer term.
Instead, it will be an efficacy study, where...
Related Articles
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...